KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Asset Utilization Ratio: 2011-2025

Historic Asset Utilization Ratio for Nektar Therapeutics (NKTR) over the last 14 years, with Sep 2025 value amounting to 0.25.

  • Nektar Therapeutics' Asset Utilization Ratio fell 13.98% to 0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25, marking a year-over-year decrease of 13.98%. This contributed to the annual value of 0.28 for FY2024, which is 72.51% up from last year.
  • As of Q3 2025, Nektar Therapeutics' Asset Utilization Ratio stood at 0.25, which was down 23.86% from 0.32 recorded in Q2 2025.
  • In the past 5 years, Nektar Therapeutics' Asset Utilization Ratio registered a high of 0.32 during Q2 2025, and its lowest value of 0.07 during Q2 2021.
  • Over the past 3 years, Nektar Therapeutics' median Asset Utilization Ratio value was 0.25 (recorded in 2025), while the average stood at 0.24.
  • In the last 5 years, Nektar Therapeutics' Asset Utilization Ratio dropped by 27.99% in 2021 and then soared by 73.79% in 2023.
  • Nektar Therapeutics' Asset Utilization Ratio (Quarterly) stood at 0.09 in 2021, then skyrocketed by 45.01% to 0.12 in 2022, then soared by 73.79% to 0.21 in 2023, then soared by 50.00% to 0.32 in 2024, then fell by 13.98% to 0.25 in 2025.
  • Its Asset Utilization Ratio stands at 0.25 for Q3 2025, versus 0.32 for Q2 2025 and 0.31 for Q1 2025.